Indole-2-carboxylic acid
Indole-2-carboxylic acid (I2CA) is a competitive antagonist of the glycine site of the NMDA receptor (Ki=15 μM, 5-fluoro-I2CA) and an inhibitor of HIV-1 integrase. Indole-2-carboxylic acid is selective for the glycine site of the NMDA receptor and blocks the enhancement of NMDA receptor by competitively inhibiting the binding of glycine to the NMDA receptor. Indole-2-carboxylic acid can also inhibit the strand transfer activity of HIV-1 integrase by chelating Mg2+ at the active site of integrase and interacting with the hydrophobic cavity. Indole-2-carboxylic acid can be used in the study of neurological diseases (such as stroke, epilepsy) and HIV-1 infection[1][2].
Product Specifications
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
HIV; HIV Integrase; iGluR
Type
Natural Products
Related Pathways
Anti-infection; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/indole-2-carboxylic-acid.html
Purity
99.97
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL (ultrasonic)
Smiles
O=C(C(N1)=CC2=C1C=CC=C2)O
Molecular Formula
C9H7NO2
Molecular Weight
161.16
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-I0096/Indole-2-carboxylic-acid-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-I0096/Indole-2-carboxylic-acid-SDS-MedChemExpress.pdf
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite; NMDA Receptor
CAS Number
[1477-50-5]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Human aZGP1 (Alpha-2-Glycoprotein 1, Zinc Binding) ELISA Kit
Lentiviral human TXK shRNA (UAS) - Lentiviral human TXK shRNA (UAS, RFP) (25)